Author: Chong, Yong Pil; Song, Joon Young; Seo, Yu Bin; Choi, Jae-Phil; Shin, Hyoung-Shik
Title: Antiviral Treatment Guidelines for Middle East Respiratory Syndrome Cord-id: qg73804g Document date: 2015_9_30
ID: qg73804g
Snippet: Middle East respiratory syndrome (MERS) is an acute infectious disease of the respiratory system caused by the new betacoronavirus (MERS coronavirus, MERS-CoV), which shows high mortality rates. The typical symptoms of MERS are fever, cough, and shortness of breath, and it is often accompanied by pneumonia. The MERS-CoV was introduced to Republic of Korea in May 2015 by a patient returning from Saudi Arabia. The disease spread mostly through hospital infections, and by the time the epidemic ende
Document: Middle East respiratory syndrome (MERS) is an acute infectious disease of the respiratory system caused by the new betacoronavirus (MERS coronavirus, MERS-CoV), which shows high mortality rates. The typical symptoms of MERS are fever, cough, and shortness of breath, and it is often accompanied by pneumonia. The MERS-CoV was introduced to Republic of Korea in May 2015 by a patient returning from Saudi Arabia. The disease spread mostly through hospital infections, and by the time the epidemic ended in August, the total number of confirmed diagnoses was 186, among which 36 patients died. Reflecting the latest evidence for antiviral drugs in the treatment of MERS-CoV infection and the experiences of treating MERS patients in Republic of Korea, these guidelines focus on antiviral drugs to achieve effective treatment of MERS-CoV infections.
Search related documents:
Co phrase search for related documents- absolute standard and acute sars cov respiratory syndrome coronavirus: 1, 2, 3
- academic paper and acute respiratory syndrome: 1
- acinetobacter spp and acute respiratory syndrome: 1, 2
Co phrase search for related documents, hyperlinks ordered by date